These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
141 related articles for article (PubMed ID: 24592173)
1. Development and characterization of nanoparticles for the delivery of gemcitabine hydrochloride. Khaira R; Sharma J; Saini V ScientificWorldJournal; 2014; 2014():560962. PubMed ID: 24592173 [TBL] [Abstract][Full Text] [Related]
2. Co-delivery of gemcitabine and simvastatin through PLGA polymeric nanoparticles for the treatment of pancreatic cancer: in-vitro characterization, cellular uptake, and pharmacokinetic studies. Jamil A; Aamir Mirza M; Anwer MK; Thakur PS; Alshahrani SM; Alshetaili AS; Telegaonkar S; Panda AK; Iqbal Z Drug Dev Ind Pharm; 2019 May; 45(5):745-753. PubMed ID: 30632800 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of Pancreatic Cancer Therapy Efficacy by Type-1 Matrix Metalloproteinase-Functionalized Nanoparticles for the Selective Delivery of Gemcitabine and Erlotinib. Yin N; Yu H; Zhang X; Lv X Drug Des Devel Ther; 2020; 14():4465-4475. PubMed ID: 33122890 [TBL] [Abstract][Full Text] [Related]
4. An in vitro and in vivo study of gemcitabine-loaded albumin nanoparticles in a pancreatic cancer cell line. Yu X; Di Y; Xie C; Song Y; He H; Li H; Pu X; Lu W; Fu D; Jin C Int J Nanomedicine; 2015; 10():6825-34. PubMed ID: 26586944 [TBL] [Abstract][Full Text] [Related]
5. Gemcitabine hydrochloride-loaded liposomes and nanoparticles: comparison of encapsulation efficiency, drug release, particle size, and cytotoxicity. Yalcin TE; Ilbasmis-Tamer S; Ibisoglu B; Özdemir A; Ark M; Takka S Pharm Dev Technol; 2018 Jan; 23(1):76-86. PubMed ID: 28724327 [TBL] [Abstract][Full Text] [Related]
6. Building and behavior of a pH-stimuli responsive chitosan nanoparticles loaded with folic acid conjugated gemcitabine silver colloids in MDA-MB-453 metastatic breast cancer cell line and pharmacokinetics in rats. Karuppaiah A; Babu D; Selvaraj D; Natrajan T; Rajan R; Gautam M; Ranganathan H; Siram K; Nesamony J; Sankar V Eur J Pharm Sci; 2021 Oct; 165():105938. PubMed ID: 34256103 [TBL] [Abstract][Full Text] [Related]
7. Long-circulatory nanoparticles for gemcitabine delivery: Development and investigation of pharmacokinetics and in-vivo anticancer efficacy. Khare V; Singh A; Mahajan G; Alam N; Kour S; Gupta M; Kumar A; Singh G; Singh SK; Saxena AK; Mondhe DM; Gupta PN Eur J Pharm Sci; 2016 Sep; 92():183-93. PubMed ID: 27404580 [TBL] [Abstract][Full Text] [Related]
8. Chitosan-Pluronic nanoparticles as oral delivery of anticancer gemcitabine: preparation and in vitro study. Hosseinzadeh H; Atyabi F; Dinarvand R; Ostad SN Int J Nanomedicine; 2012; 7():1851-63. PubMed ID: 22605934 [TBL] [Abstract][Full Text] [Related]
9. Design and evaluation of an intravesical delivery system for superficial bladder cancer: preparation of gemcitabine HCl-loaded chitosan-thioglycolic acid nanoparticles and comparison of chitosan/poloxamer gels as carriers. Şenyiğit ZA; Karavana SY; İlem-Özdemir D; Çalışkan Ç; Waldner C; Şen S; Bernkop-Schnürch A; Baloğlu E Int J Nanomedicine; 2015; 10():6493-507. PubMed ID: 26508855 [TBL] [Abstract][Full Text] [Related]
10. Development and characterization of folic acid-conjugated chitosan nanoparticles for targeted and controlled delivery of gemcitabinein lung cancer therapeutics. Wang F; Wang Y; Ma Q; Cao Y; Yu B Artif Cells Nanomed Biotechnol; 2017 Dec; 45(8):1530-1538. PubMed ID: 27894196 [TBL] [Abstract][Full Text] [Related]
11. Gemcitabine delivered by fucoidan/chitosan nanoparticles presents increased toxicity over human breast cancer cells. Oliveira C; Neves NM; Reis RL; Martins A; Silva TH Nanomedicine (Lond); 2018 Aug; 13(16):2037-2050. PubMed ID: 30189774 [TBL] [Abstract][Full Text] [Related]
12. Preparation, physicochemical characterization and cytotoxicity in vitro of gemcitabine-loaded PEG-PDLLA nanovesicles. Jia L; Zheng JJ; Jiang SM; Huang KH World J Gastroenterol; 2010 Feb; 16(8):1008-13. PubMed ID: 20180242 [TBL] [Abstract][Full Text] [Related]
13. Enhanced tumor targeting of cRGD peptide-conjugated albumin nanoparticles in the BxPC-3 cell line. Yu X; Song Y; Di Y; He H; Fu D; Jin C Sci Rep; 2016 Aug; 6():31539. PubMed ID: 27515795 [TBL] [Abstract][Full Text] [Related]
14. Development and evaluation of folate functionalized albumin nanoparticles for targeted delivery of gemcitabine. Dubey RD; Alam N; Saneja A; Khare V; Kumar A; Vaidh S; Mahajan G; Sharma PR; Singh SK; Mondhe DM; Gupta PN Int J Pharm; 2015 Aug; 492(1-2):80-91. PubMed ID: 26165611 [TBL] [Abstract][Full Text] [Related]
15. Novel Gemcitabine Conjugated Albumin Nanoparticles: a Potential Strategy to Enhance Drug Efficacy in Pancreatic Cancer Treatment. Kushwah V; Agrawal AK; Dora CP; Mallinson D; Lamprou DA; Gupta RC; Jain S Pharm Res; 2017 Nov; 34(11):2295-2311. PubMed ID: 28795274 [TBL] [Abstract][Full Text] [Related]
16. A Novel Delivery System of RGD-HSA Loaded GEM/CUR Nanoparticles for the Treatment of Pancreatic Cancer Therapy. Ma T; Jiang JL; Qi WX; Chen JY; Xu HP Drug Des Devel Ther; 2022; 16():2395-2406. PubMed ID: 35923931 [TBL] [Abstract][Full Text] [Related]
17. Co-delivery of docetaxel and gemcitabine by anacardic acid modified self-assembled albumin nanoparticles for effective breast cancer management. Kushwah V; Katiyar SS; Dora CP; Kumar Agrawal A; Lamprou DA; Gupta RC; Jain S Acta Biomater; 2018 Jun; 73():424-436. PubMed ID: 29649635 [TBL] [Abstract][Full Text] [Related]
18. Combination therapy for the treatment of pancreatic cancer through hyaluronic acid-decorated nanoparticles loaded with quercetin and gemcitabine: A preliminary in vitro study. Serri C; Quagliariello V; Iaffaioli RV; Fusco S; Botti G; Mayol L; Biondi M J Cell Physiol; 2019 Apr; 234(4):4959-4969. PubMed ID: 30334571 [TBL] [Abstract][Full Text] [Related]
19. Gemcitabine cationic polymeric nanoparticles against ovarian cancer: formulation, characterization, and targeted drug delivery. Bhattacharya S; Anjum MM; Patel KK Drug Deliv; 2022 Dec; 29(1):1060-1074. PubMed ID: 35363113 [TBL] [Abstract][Full Text] [Related]
20. pH-Sensitive Nanodrug Carriers for Codelivery of ERK Inhibitor and Gemcitabine Enhance the Inhibition of Tumor Growth in Pancreatic Cancer. Ray P; Dutta D; Haque I; Nair G; Mohammed J; Parmer M; Kale N; Orr M; Jain P; Banerjee S; Reindl KM; Mallik S; Kambhampati S; Banerjee SK; Quadir M Mol Pharm; 2021 Jan; 18(1):87-100. PubMed ID: 33231464 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]